openPR Logo
Press release

Deep Brain Stimulation Devices Market - Global Industry Analysis 2024

02-23-2017 04:36 PM CET | Health & Medicine

Press release from: Deep Brain Stimulation Devices Market

Deep Brain Stimulation Devices Market - Global Industry

Deep brain stimulation (DBS) surgery is carried out as part of treatment of various neural debilitating conditions such as Parkinson’s disease, dementia, and Alzheimer’s disease. Patients fitted with a deep brain stimulation device can get long-term relief from debilitating symptoms of Parkinson’s disease. There is significant reduction in side-effects caused due to medications, though medications may be required in some patient post-surgery. The DBS device is mainly placed in one of the three FDA approved target sites in Parkinson’s disease. Most commonly preferred target sites are the Globus Pallidus Interna (GPi) and Subthalamic Nucleus (STN).

Get Free PDF Research Brochure for more Professional and Technical Insights: https://www.coherentmarketinsights.com/insight/request-sample/84

Market Dynamics

Aging increases the risk of Alzheimer’s disease, Parkinson’s disease and dementia. Thus, growing geriatric population is a major factor driving demand for deep brain stimulation devices. Though drug therapies are available for treating these diseases, surgical procedures are recommended in later stages of the condition. Furthermore, deep brain stimulation devices reduce the side effects and improves patient condition by reducing incidence of tremors. Patients are inclined towards adoption of minimally invasive procedures, as these require low healing time and leave behind minimal scars. Surgeons too prefer such procedures as it significantly reduces risk element from accidental damage to surrounding tissue. This is another factor fueling demand for deep brain stimulation devices globally. However, as these devices need to be implanted in the brain, it is extremely challenging and in turn reduces acceptance of DBS devices among patients.

Market Taxonomy

This report segments the global deep brain stimulation devices market on the basis of application and geography. Applications of deep brain stimulation devices are Parkinson's disease, essential tremor, dystonia, and others. For comprehensive understanding of market dynamics, the global market has been divided into key geographical regions, namely North America, Europe, Asia Pacific, Latin America, Africa, and Middle East. Each of these regions is further segmented on the basis of major countries for a macro-level understanding of the market.

Key features of the study:

This report provides in-depth analysis of the deep brain stimulation devices and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2016 – 2024, considering 2015 as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players

It profiles leading players in the global deep brain stimulation devices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans

Browse Global Strategic Business Report : https://www.coherentmarketinsights.com/market-insight/deep-brain-stimulation-devices-market-84

Key companies covered as a part of this study include Aleva Neurotherapeutics SA, Boston Scientific Corporation, Medtronic, Inc., St. Jude Medical, Inc., Cyberonics, Inc., and Neuronetics

Insights from this report will allow marketers and the management authorities of companies to make informed decision with respect to their future product launch, technology upgrades, market expansion, and marketing tactics

The global deep brain stimulation devices market report caters to various stakeholders in this industry, including investors, device manufacturers, distributors, new entrants, and financial analysts

Various strategy matrices used in analyzing the deep brain stimulation devices market would provide stakeholders vital inputs to make strategic decisions accordingly

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit Coherent Market Insights Blog @ https://blog.coherentmarketinsights.com/
Connect with us on LinkedIn @ https://www.linkedin.com/company/coherent-market-insights

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Deep Brain Stimulation Devices Market - Global Industry Analysis 2024 here

News-ID: 447448 • Views:

More Releases from Deep Brain Stimulation Devices Market

Deep Brain Stimulation Devices Market size is expected to grow USD 3033.4 million by 2030
Deep Brain Stimulation Devices Market size is expected to grow USD 3033.4 millio …
According to the Market Statsville Group (MSG), the global deep brain stimulation devices market size is expected to grow from USD 1,318.5 million in 2021 to USD 3033.4 million by 2030, at a CAGR of 9.7% from 2022 to 2030. The deep brain stimulation (DBS) device, also known as a brain pacemaker, assists in relieving parkinson's disease symptoms (PD). The device is implanted in one of three FDA-approved brain locations
Global Deep Brain Stimulation Devices Market 2019-2024| Medtronic, Boston Scientific, St Jude Medical, Beijing Pins, SceneRay
Global Deep Brain Stimulation Devices Market 2019-2024| Medtronic, Boston Scient …
Albany, NY, 19th April : Recent research and the current scenario as well as future market potential of "Global Deep Brain Stimulation Devices Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024" globally. Deep brain stimulation (DBS) is a neurosurgical procedure involving the implantation of a medical device called a neurostimulator (sometimes referred to as a 'brain pacemaker'), which sends electrical impulses, through implanted electrodes, to specific targets in
Deep Brain Stimulation Devices Market Report 2018 Companies included Medtronic, Boston Scientific, St Jude Medical, Beijing Pins, SceneRay and Others
Deep Brain Stimulation Devices Market Report 2018 Companies included Medtronic, …
We have recently published this report and it is available for immediate purchase. For inquiry Email us on: jasonsmith@marketreportscompany.com ********* This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides
Deep Brain Stimulation Devices Market Report for Period 2018 till 2024 Medtronic, Boston Scientific, Beijing Pins and Others.
Deep Brain Stimulation Devices Market Report for Period 2018 till 2024 Medtronic …
Global Deep Brain Stimulation Devices market report emphasizes on detailed analysis of companies and manufacturers like St Jude Medical, Beijing Pins, SceneRay, Medtronic, Boston Scientific and Others. Deep brain stimulation (DBS) is a neurosurgical procedure involving the implantation of a medical device called a neurostimulator (sometimes referred to as a brain pacemaker), which sends electrical impulses, through implanted electrodes, to specific targets in the brain (brain nuclei) for the treatment

All 5 Releases


More Releases for Parkinson

Key Trends Reshaping the Wolff Parkinson White Syndrome Market: Technological Ad …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations. Wolff Parkinson White Syndrome Market Size Growth Forecast: What to Expect by 2025? The market for Wolff Parkinson White syndrome has registered consistent growth over the recent past. The expectation is that it will expand from $1.17 billion in 2024 to $1.22 billion in 2025, reflecting a compound annual growth rate (CAGR) of 4.5%.
Evolving Market Trends In The Anti-Parkinson Drugs Industry: Innovative Advancem …
The Anti-Parkinson Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Anti-Parkinson Drugs Market Size During the Forecast Period? The anti-parkinson drugs market has seen significant growth in recent years, projected to increase from $10.37 billion in 2024 to $11.08 billion in
What's Driving the Anti-Parkinson Drugs Market 2025-2034: Increasing Geriatric P …
What Are the Projections for the Size and Growth Rate of the Anti-Parkinson Drugs Market? In recent times, the market size for anti-Parkinson drugs has experienced robust growth. The market, which is projected to rise from $10.37 billion in 2024 to $11.08 billion in 2025, boasts a compound annual growth rate (CAGR) of 6.9%. The past growth trend can be credited to an aging demographic, a surge in disease incidence, enhanced
What's Driving the Anti-Parkinson Drugs Market 2025-2034: Increasing Geriatric P …
What Are the Projections for the Size and Growth Rate of the Anti-Parkinson Drugs Market? In recent times, the market size for anti-Parkinson drugs has experienced robust growth. The market, which is projected to rise from $10.37 billion in 2024 to $11.08 billion in 2025, boasts a compound annual growth rate (CAGR) of 6.9%. The past growth trend can be credited to an aging demographic, a surge in disease incidence, enhanced
Wolff Parkinson White Syndrome Treatment Market Overview 2024-2033
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033. Wolff Parkinson White Syndrome Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance. The Market Size Is Expected To Reach $1.43 billion
Anti-Parkinson Drugs Market Overview
Exhibiting robust growth, the anti-parkinson drugs market is set to escalate from $9.73 billion in 2023 to $10.43 billion in 2024, with a notable Compound Annual Growth Rate (CAGR) of 7.2%. The trajectory continues on an upward trend, with an anticipated market size of $13.36 billion by 2028, sustaining a robust CAGR of 6.4%. Increasing Geriatric Population Driving Demand: The burgeoning geriatric population, coupled with a surge in Parkinson's disease cases,